News
Five cancer drugs back on NHS list after deals with drug companies
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5985 (Published 06 November 2015) Cite this as: BMJ 2015;351:h5985- Nigel Hawkes
- 1London
Five cancer drugs have been reinstated on the list paid for by England’s Cancer Drugs Fund, after manufacturers provided discounts to make them more affordable.
The fund faces rising costs, and in September it announced the removal of 16 drugs used in 23 treatments, in an attempt to balance its books.1 Thanks to the new deal it has now been able to reinstate five, used in seven treatments, reducing the number of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.